Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hagit
Hagit Ashush, Ashkelon IL
| Patent application number | Description | Published |
|---|---|---|
| 20110190380 | METHODS FOR DELIVERY OF SIRNA TO BONE MARROW CELLS AND USES THEREOF - The present invention relates to a method for the delivery of therapeutic oligonucleotides to bone marrow, and in particular delivery of siRNA to a subset of bone marrow cells. The method comprises systemically administering siRNA to a subject in need thereof, to reduce or inhibit expression of a gene associated with a disease or disorder or to symptoms associated with a disease or disorder associated with the cells. The invention further relates to chemically modified siRNA compounds, to pharmaceutical compositions comprising such compounds and to methods of using such compounds and compositions in the treatment of disease. | 08-04-2011 |
Hagit Eldar-Finkelman, Shoham IL
| Patent application number | Description | Published |
|---|---|---|
| 20080312188 | Glycogen synthase kinase-3 inhibitors - Novel compounds designed to allow interactions with binding sites of GSK-3 and hence are capable of inhibiting GSK-3 activity, via inhibition of substrate binding are disclosed. Further disclosed are pharmaceutical compositions including same and methods of using same in the treatment of GSK-3 mediated conditions. | 12-18-2008 |
| 20090062180 | Glycogen synthase kinase-3 inhibitors - Novel conjugates that are capable of inhibiting GSK-3 activity, a process of producing same, pharmaceutical compositions including same and methods of using same in the treatment of GSK-3 mediated conditions are disclosed. Methods of treating affective disorders using GSK-3 inhibitors are further disclosed. | 03-05-2009 |
Hagit Elmaleh, Ormesson Sur Marne FR
| Patent application number | Description | Published |
|---|---|---|
| 20110144362 | CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING THE SAME - The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β, 10β-dimethoxy-9-oxo-tax-11-ene-13α-yl, and to the preparation thereof. | 06-16-2011 |
Hagit Frenkel-Mullerad, Galil-Ma'Aravi IL
| Patent application number | Description | Published |
|---|---|---|
| 20110065139 | DIAGNOSTIC DEVICE FOR IDENTIFYING RUPTURE OF MEMBRANE DURING PREGNANCY - A diagnostic device is provided for distinguishing between amniotic fluid and urine in female secretion. The device can be employed as a panty shield or can be adhered onto a panty shield or can be employed in a simple pad that is pressed against a substrate provided with female secretion. | 03-17-2011 |
Hagit Gershtenman-Avsian, Huntersville, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20110181854 | FOCUS COMPENSATION FOR OPTICAL ELEMENTS AND APPLICATIONS THEREOF - Optical imaging apparatus are provided having the desired focal properties, which can be manufactured and/or assembled at the wafer level. | 07-28-2011 |
Hagit Hamdani, Haifa IL
| Patent application number | Description | Published |
|---|---|---|
| 20110066686 | Public BOT Management in Private Networks - A system for managing the use of BOTs by computer network users, the system including a gateway-to-BOT communications manager configured to relay communications to a BOT on behalf of a computer user in a manner that prevents the BOT from associating the communications with the computer user, and a gateway-to-user communications manager configured to relay the communications from the computer user to the gateway-to-BOT communications manager, and relay to the computer user communications received from the gateway-to-BOT communications manager that originate from the BOT. | 03-17-2011 |
Hagit Krug, Bar Yam IL
| Patent application number | Description | Published |
|---|---|---|
| 20110274647 | IL6R/IL6 Chimera for Therapy of Chemotherapy-Induced Peripheral Neuropathy - The invention relates to the use of IL-6R/IL-6 chimera in chemotherapy induced neuropathy. | 11-10-2011 |
Hagit Messer-Yaron, Kfar Saba IL
| Patent application number | Description | Published |
|---|---|---|
| 20090160700 | Monitoring and Mapping of Atmospheric Phenomena - A computerized system for mapping an atmospheric phenomenon in a geographic region. Multiple free-space electromagnetic communications links are previously distributed in the geographic region. The system includes an interface to monitoring mechanisms attached respectively to the free-space electromagnetic communications links. The monitoring mechanisms respectively monitor attenuation levels of the free-space electromagnetic communications links. A processor simultaneously processes the attenuation levels, and maps in the geographic region the atmospheric phenomenon. The simultaneous processing preferably applies a non-linear model which relates the attenuation levels the atmospheric phenomenon, and solves a tomographic problem based on the non-linear model and the attenuation levels. The tomographic problem is preferably solved by an interactive algorithm based on consecutive refinement and linear inversion at each iteration. Alternatively, an interpolation is performed based on respective inverse distance from the communications links. Preferably, the interpolation is further based on respective lengths of communications links. A data interface preferably provides to subscribers temporal information related to the atmospheric phenomenon within portions of the geographic region. | 06-25-2009 |
Hagit Shilo-Volin, Meytar IL
| Patent application number | Description | Published |
|---|---|---|
| 20110008267 | Pharmaceutical and Cosmeceutical Wash-Off Mousse Shampoo Compositions, Processes for Preparing the Same and Uses Thereof - A method for treating a disease or disorder of the skin or scalp of a mammal while simultaneously cleansing the skin or scalp is disclosed. The method includes administering to the skin or scalp a mousse formed from a composition that includes a therapeutically or cosmeceutically effective amount of at least one active pharmaceutical ingredient, 10% to 50% by weight of a cleansing agent selected from the group consisting of anionic surfactants, nonionic surfactants and combinations thereof, a pharmaceutically acceptable mousse-forming carrier that includes a propellant, the propellant being 3% to 50% by weight of the composition, and water being about 40% to about 90% by weight of the composition, waiting a period of time; and rinsing said skin or scalp with water to remove the mousse. | 01-13-2011 |